Literature DB >> 18461430

Persistent iatrogenic atrial septal defect after pulmonary vein isolation : incidence and clinical implications.

Andreas Rillig1, Udo Meyerfeldt, Ralf Birkemeyer, Fabian Treusch, Markus Kunze, Werner Jung.   

Abstract

INTRODUCTION: Pulmonary vein isolation (PVI) is widely practiced for treating atrial fibrillation. Transseptal access is necessary with one or even more transseptal sheaths to perform PVI.
METHODS: In this prospective study, 31 patients were examined with transesophageal echocardiography before, immediately after and in a 3-, 6- and 12-month follow-up period for evaluation of iatrogenic atrial septal defect (iASD). All patients underwent PVI with double transseptal puncture.
RESULTS: An iASD was detected in 27/31 patients (87%) with a maximum diameter of 1.0 mm. After 3 months, the iASDs were completely closed in 26/27 (96.3%) patients. In 1/27 (3.7%) patients, there was an iASD detectable even after 12 months. Clinically no patient suffered from cerebral or cardiac embolism in the follow-up period.
CONCLUSIONS: We were only able to find small iASDs with left to right shunting after PVI but none with right to left shunting. iASDs following PVI show a high spontaneous closure rate already at 3 months of follow-up and are not associated with an increased rate of paradoxical embolism.

Entities:  

Mesh:

Year:  2008        PMID: 18461430     DOI: 10.1007/s10840-008-9257-7

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  20 in total

1.  Transcatheter creation of an atrial septal defect using radiofrequency perforation.

Authors:  H Justino; L N Benson; D G Nykanen
Journal:  Catheter Cardiovasc Interv       Date:  2001-09       Impact factor: 2.692

2.  Transcatheter creation of atrial septal perforation using a radiofrequency transseptal system: novel approach as an alternative to transseptal needle puncture.

Authors:  Yoshihito Sakata; Ted Feldman
Journal:  Catheter Cardiovasc Interv       Date:  2005-03       Impact factor: 2.692

3.  Circumferential pulmonary-vein ablation for chronic atrial fibrillation.

Authors:  Hakan Oral; Carlo Pappone; Aman Chugh; Eric Good; Frank Bogun; Frank Pelosi; Eric R Bates; Michael H Lehmann; Gabriele Vicedomini; Giuseppe Augello; Eustachio Agricola; Simone Sala; Vincenzo Santinelli; Fred Morady
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

4.  Persistence of iatrogenic atrial septal defect after pulmonary vein isolation--an underestimated risk?

Authors:  Christoph Hammerstingl; Lars Lickfett; Kyung-Mi Jeong; Clemens Troatz; Jan-Arne Wedekind; Klaus Tiemann; Berndt Lüderitz; Thorsten Lewalter
Journal:  Am Heart J       Date:  2006-08       Impact factor: 4.749

5.  Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias.

Authors:  Michel Haïssaguerre; Mélèze Hocini; Prashanthan Sanders; Frederic Sacher; Martin Rotter; Yoshihide Takahashi; Thomas Rostock; Li-Fern Hsu; Pierre Bordachar; Sylvain Reuter; Raymond Roudaut; Jacques Clémenty; Pierre Jaïs
Journal:  J Cardiovasc Electrophysiol       Date:  2005-11

6.  Microsurgical anatomy of the middle cerebral artery.

Authors:  H Gibo; C C Carver; A L Rhoton; C Lenkey; R J Mitchell
Journal:  J Neurosurg       Date:  1981-02       Impact factor: 5.115

7.  Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation.

Authors:  Lars Lickfett; Matthias Hackenbroch; Thorsten Lewalter; Stephanie Selbach; Jörg O Schwab; Alexander Yang; Osman Balta; Jan Schrickel; Alexander Bitzen; Berndt Lüderitz; Torsten Sommer
Journal:  J Cardiovasc Electrophysiol       Date:  2006-01

8.  Assessment of left-to-right atrial shunting after percutaneous mitral valvuloplasty by transesophageal color Doppler flow-mapping.

Authors:  K Yoshida; J Yoshikawa; T Akasaka; Y Yamaura; M Shakudo; T Hozumi; T Fukaya
Journal:  Circulation       Date:  1989-12       Impact factor: 29.690

9.  Association of interatrial shunts and migraine headaches: impact of transcatheter closure.

Authors:  Babak Azarbal; Jonathan Tobis; William Suh; Vicki Chan; Catherine Dao; Richard Gaster
Journal:  J Am Coll Cardiol       Date:  2005-02-15       Impact factor: 24.094

10.  Trans-septal catheterization in the electrophysiology laboratory: data from a multicenter survey spanning 12 years.

Authors:  Roberto De Ponti; Riccardo Cappato; Antonio Curnis; Paolo Della Bella; Luigi Padeletti; Antonio Raviele; Massimo Santini; Jorge A Salerno-Uriarte
Journal:  J Am Coll Cardiol       Date:  2006-02-09       Impact factor: 24.094

View more
  19 in total

1.  Long-term follow-up of iatrogenic atrial septal defect: after percutaneous mitral balloon valvuloplasty.

Authors:  Sule Korkmaz; Burcu Demirkan; Yesim Guray; Mehmet Birhan Yilmaz; Hatice Sasmaz
Journal:  Tex Heart Inst J       Date:  2011

2.  First experience of percutaneous radio-frequency ablation for atrial flutter and atrial fibrillation in a patient with HeartMate II left ventricular assist device.

Authors:  Philippe Maury; Clement Delmas; Charlotte Trouillet; Mark S Slaughter; Olivier Lairez; Michel Galinier; Jerome Roncalli; David Bertrand; Lydie Mathevet; Alexandre Duparc; Michelle Salvador; Marc Delay; Camille Dambrin
Journal:  J Interv Card Electrophysiol       Date:  2010-10       Impact factor: 1.900

3.  Treatment Complications of Atrial Fibrillation and Their Management.

Authors:  Allan Mattia; Joshua Newman; Frank Manetta
Journal:  Int J Angiol       Date:  2020-03-05

Review 4.  Collateral Damage During Ablation of Atrial Fibrillation - Lessons Learnt in the Past Decade.

Authors:  David Spragg
Journal:  J Atr Fibrillation       Date:  2012-02-02

Review 5.  Catheter Ablation of Atrial Fibrillation in Patients with Hardware in the Heart - Septal Closure Devices, Mechanical Valves and More.

Authors:  Stefano Bartoletti; Pasquale Santangeli; Luigi DI Biase; Andrea Natale
Journal:  J Atr Fibrillation       Date:  2013-06-30

Review 6.  Comparing Antiarrhythmic Drugs and Catheter Ablation for Treatment of Atrial Fibrillation.

Authors:  Andreas Rillig; Tina Lin; Feifan Ouyang; Karl Heinz Kuck; Roland Richard Tilz
Journal:  J Atr Fibrillation       Date:  2013-06-30

Review 7.  A Patient With Asymptomatic Cerebral Lesions During AF Ablation: How Much Should We Worry?

Authors:  Giovanni B Forleo; Domenico G Della Rocca; Carlo Lavalle; Massimo Mantica; Lida P Papavasileiou; Valentina Ribatti; Germana Panattoni; Luca Santini; Andrea Natale; Luigi Di Biase
Journal:  J Atr Fibrillation       Date:  2016-02-29

8.  Persistence of an iatrogenic atrial septal defect after a second-generation cryoballoon ablation of atrial fibrillation.

Authors:  Tomonori Watanabe; Shinsuke Miyazaki; Takatsugu Kajiyama; Sadamitsu Ichijo; Takamitsu Takagi; Miyako Igarashi; Hiroaki Nakamura; Hiroshi Taniguchi; Hitoshi Hachiya; Yoshito Iesaka
Journal:  Heart Vessels       Date:  2018-03-17       Impact factor: 2.037

9.  A streamlined technique of trans-septal endocardial left ventricular lead placement.

Authors:  Ernest W Lau
Journal:  J Interv Card Electrophysiol       Date:  2009-04-22       Impact factor: 1.900

10.  Persistent iatrogenic atrial septal defects after pulmonary vein isolation: long-term follow-up with contrast transesophageal echocardiography.

Authors:  Allan Davies; Prasad Gunaruwan; Nicholas Collins; Malcolm Barlow; Nick Jackson; James Leitch
Journal:  J Interv Card Electrophysiol       Date:  2016-09-28       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.